CCM
DVAX

Clovis Capital Management’s Dynavax Technologies DVAX Stock Holding History

Clovis Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-200,000
Closed -$2.1M – 15
2016
Q3 		$2.1M Buy
+200,000
New +$2.87M 0.66% 18
2015
Q3 		– Sell
-350,000
Closed -$8.2M – 16
2015
Q2 		$8.2M Buy
+350,000
New +$7.62M 2.52% 13

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Clovis Capital Management's DVAX Position: Q1 2017 in Review

Clovis Capital Management sold out of Dynavax Technologies (DVAX) in Q1 2017, closing a stake of 41,669 shares — an estimated $165K sold.

Clovis Capital Management first reported a position in DVAX in Q1 2015 and held it in 8 quarters. The position peaked at $10.4M in Q3 2015. 101 funds tracked by Wall St. Rank hold DVAX as of Q1 2017.

  • Clovis Capital Management reported no remaining Dynavax Technologies position as of Q1 2017 after selling out during the quarter.
  • Clovis Capital Management sold 41,669 Dynavax Technologies shares in Q1 2017, an estimated $165K.
  • Clovis Capital Management first reported a position in Dynavax Technologies in Q1 2015 and held it in 8 quarters.
  • Clovis Capital Management's Dynavax Technologies position peaked at $10.4M in Q3 2015.
  • 101 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2017.

Based on Clovis Capital Management's 13F filing for Q1 2017.